imatinib mesylate has been researched along with Herpes Zoster in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cortes, JE; Ferrajoli, A; Giles, FJ; Kantarjian, HM; Kontoyiannis, D; Mattiuzzi, GN; Raad, I; Reuben, J; Rios, MB; Shan, J; Talpaz, M; Verstovsek, S | 1 |
| Durosinmi, MA; Ogbe, PO; Oyekunle, AA; Salawu, L | 1 |
2 other study(ies) available for imatinib mesylate and Herpes Zoster
| Article | Year |
|---|---|
Development of Varicella-Zoster virus infection in patients with chronic myelogenous leukemia treated with imatinib mesylate.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Chickenpox; Female; Herpes Zoster; Herpesvirus 3, Human; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pyrimidines | 2003 |
Herpes zoster complicating imatinib mesylate for gastrointestinal stromal tumour.
Topics: Acyclovir; Antiviral Agents; Bandages; Benzamides; Diagnosis, Differential; Gastrointestinal Stromal Tumors; Herpes Zoster; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Protein-Tyrosine Kinases; Pyrimidines | 2007 |